Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design-Reference-Cited by-同舟云学术

Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design

Published:2021-10 Issue:10 Volume:11 Page:3060-3091
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Qiao Qi^ORCID,Liu Xiong^ORCID,Yang Ting,Cui Kexin,Kong Li,Yang Conglian,Zhang Zhiping

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference255 articles.

1. Acute respiratory distress syndrome: advances in diagnosis and treatment;Fan;J Am Med Assoc,2018

2. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 Countries;Bellani;J Am Med Assoc,2016

3. Acute respiratory distress syndrome;Thompson;N Engl J Med,2017

4. Acute respiratory failure in COVID-19: is it "typical" ARDS?;Li;Crit Care,2020

5. Immunopathogenesis of coronavirus-induced acute respiratory distress syndrome (ARDS): potential infection-associated hemophagocytic lymphohistiocytosis;Quan;Clin Microbiol Rev,2021

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Intratracheal administration of programmable DNA nanostructures combats acute lung injury by targeting microRNA-155;International Journal of Pharmaceutics;2024-02

3. A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century;Advanced Materials;2024-01-17

4. Translational medicine for acute lung injury;Journal of Translational Medicine;2024-01-05

5. Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome;ACS Nano;2024-01-03